ClinConnect ClinConnect Logo
Search / Trial NCT04453072

A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults After a Stem Cell Transplant

Launched by JONSSON COMPREHENSIVE CANCER CENTER · Jun 29, 2020

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is exploring whether a special weight management app for iPhones, along with coaching, can help adolescents and young adults lose weight after they have undergone a stem cell transplant. The researchers hope to understand how this approach can encourage healthy eating habits and successful weight loss in young people who are struggling with obesity.

To be eligible for the study, participants must be at least 100 days post-transplant and classified as obese, meaning their body weight is higher than what is considered healthy for their age and gender. The study is open to both males and females, and participants should be able to read English since the app is only available in that language. If you or your child meet these criteria, you can expect to use the app with guidance from a coach to help achieve weight loss goals. It's important to note that this trial is currently recruiting participants, so you have the opportunity to take part in this potentially beneficial program.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with a history of HSCT of any type, at least 100 days post-transplant at initial consultation of the study, will be eligible for the study
  • Patients must classify as obese, represented as body mass index (BMI) \>= 85th percentile for age and gender
  • Patients must also be able to read English since the app intervention is only available in English form
  • No patients will be excluded for any specific underlying medical condition, but decisions will be made on a case by case basis if a patient's functioning is deemed to significantly interfere with intervention participation
  • * PARENT:
  • His/her child meets all inclusion criteria
  • \>= 18 years of age
  • Can speak English
  • Exclusion Criteria:
  • Patients who are \< 100 days post-transplant at initial consultation will not be eligible for the study, but may become eligible if they are \> 100 days post-transplant at their next consultation that falls within the enrollment window
  • Patients whose BMI does not fall under the obese category will be excluded

About Jonsson Comprehensive Cancer Center

The Jonsson Comprehensive Cancer Center (JCCC) is a leading research and treatment institution dedicated to advancing cancer prevention, diagnosis, and treatment through innovative clinical trials and cutting-edge research. Affiliated with the University of California, Los Angeles (UCLA), the JCCC integrates a multidisciplinary approach, bringing together experts in oncology, genetics, and public health to foster collaboration and translate scientific discoveries into effective therapies. With a commitment to improving patient outcomes and quality of life, the JCCC conducts a wide range of clinical trials aimed at addressing various cancer types, ensuring that patients have access to the most advanced therapeutic options available.

Locations

Los Angeles, California, United States

Patients applied

0 patients applied

Trial Officials

Theodore B Moore

Principal Investigator

UCLA / Jonsson Comprehensive Cancer Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials